Vistra stock was rising Tuesday after authorities lifted evacuation orders issued because of a fire at a company power plant last week. The utility stock gained 8.8% to $185.83 in afternoon trading, ...

Affirm Holdings has a bright future, but its quarterly report could prove disappointing, Susquehanna Financial Group argued. Analysts James Friedman and Madeleine Zhou downgraded shares of the “buy ...

Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several other biopharma firms. Aside from JPM conference coverage, our reporters are making their way around town for one-on ...

What casts more doubt on the 29-year-old's future, however, is the condition of his wrist. The former Wimbledon finalist suffered problems again during the match, bandaging it on one occasion due ...

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

AbbVie (ABBV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

Patients who require biologic disease-modifying antirheumatic drugs (DMARDs) for severe RA are less likely to achieve sustained DMARD-free remission than those not needing the medication. Patients ...

On December 18, a recent SEC filing unveiled that Kevin K Buckbee, SVP at AbbVie ABBV made an insider sell. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on ...

AbbVie has agreed to buy privately held biotechnology company Nimble Therapeutics for $200 million in cash in a deal that bolsters the biopharmaceutical company's expansive immunology portfolio ...